SCHEMBL6968905

SCHEMBL6968905

C#Cc1ccc2c(c1)/C(=C/c1[nH]cnc1C)C(=O)N2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NEK2 P51955 3/20 0.48
PDPK1 O15530 5/20 0.45
RET P07949 7/20 0.44
PDGFRB P09619 1/20 0.44
KDR P35968 2/20 0.42
FLT3 P36888 2/20 0.42
ALK Q9UM73 2/20 0.42
CDK2 P24941 4/20 0.41
CCNE1 P24864 3/20 0.41
TLK2 Q86UE8 3/20 0.40
PLK4 O00444 1/20 0.40
CHEK1 O14757 1/20 0.40
AURKA O14965 1/20 0.40
JAK2 O60674 1/20 0.40
ROCK2 O75116 1/20 0.40
MAP4K4 O95819 1/20 0.40
CHEK2 O96017 1/20 0.40
NTRK1 P04629 1/20 0.40
LCK P06239 1/20 0.40
CDK1 P06493 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6968911 1.00 NEK2 (0.48) NEK2PDPK1RETPDGFRBKDR
SCHEMBL6965064 0.85 PDPK1 (0.42) NEK2PDPK1RETPDGFRBKDR
SCHEMBL6964645 0.85 PDPK1 (0.42) NEK2PDPK1RETPDGFRBKDR
SCHEMBL6964379 0.82 RET (0.62) PDPK1RETPDGFRBKDRCDK2
SCHEMBL6959102 0.82 RET (0.62) PDPK1RETPDGFRBKDRCDK2
SCHEMBL6957524 0.76 CCNE1 (0.71) PDPK1RETCDK2CCNE1TLK2
SCHEMBL6957516 0.76 CCNE1 (0.71) PDPK1RETCDK2CCNE1TLK2
SCHEMBL6970904 0.73 PDPK1 (0.77) NEK2PDPK1RETPDGFRBKDR
SCHEMBL6959634 0.73 PDPK1 (0.77) NEK2PDPK1RETPDGFRBKDR
SCHEMBL146013 0.73 AURKA (0.51) NEK2PDPK1PDGFRBKDRCDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1149092-B1 4- AND 5-ALKYNYLOXINDOLES AND 4- AND 5-ALKENYLOXINDOLES HOFFMANN LA ROCHE (CH) 2003-10-29 EP claimed
CN-1331689-A 4-and 5-alkynyloxindoles and 4-and 5-alkenyloxindoles HOFFMANN LA ROCHE (CH) 2002-01-16 CN claimed
US-6313310-B1 JUN N-TERMINAL KINASE (JNK) ENZYME INHIBITORS; ANTIINFLAMMATORY AGENTS; RHEUMATIC ARTHRITIS AND NEURO-DEGENERATIVE DISEASE TREATMENT HOFFMANN-LA ROCHE INC. 2001-11-06 US claimed
EP-1149092-A2 4- AND 5-ALKYNYLOXINDOLES AND 4- AND 5-ALKENYLOXINDOLES F. HOFFMANN-LA ROCHE AG (CH) 2001-10-31 EP claimed
WO-2000035906-A2 4- AND 5-ALKYNYLOXINDOLES AND 4- AND 5-ALKENYLOXINDOLES F. HOFFMANN-LA ROCHE AG (CH) 2000-06-22 WO claimed
EP-1149092-B1 4- AND 5-ALKYNYLOXINDOLES AND 4- AND 5-ALKENYLOXINDOLES HOFFMANN LA ROCHE (CH) 2003-10-29 EP disclosed
US-6313310-B1 JUN N-TERMINAL KINASE (JNK) ENZYME INHIBITORS; ANTIINFLAMMATORY AGENTS; RHEUMATIC ARTHRITIS AND NEURO-DEGENERATIVE DISEASE TREATMENT HOFFMANN-LA ROCHE INC. 2001-11-06 US disclosed
EP-1149092-A2 4- AND 5-ALKYNYLOXINDOLES AND 4- AND 5-ALKENYLOXINDOLES F. HOFFMANN-LA ROCHE AG (CH) 2001-10-31 EP disclosed
WO-2000035906-A2 4- AND 5-ALKYNYLOXINDOLES AND 4- AND 5-ALKENYLOXINDOLES F. HOFFMANN-LA ROCHE AG (CH) 2000-06-22 WO disclosed